Discover How Qlosi Reduces Pupil Diameter with Minimal Ciliary Impact

Pilot Study Uncovers Qlosi’s Unique Effects on Pupil Diameter

A recent study presented at the Hawaiian Eye 2026 Conference has highlighted the intriguing effects of Qlosi (pilocarpine hydrochloride ophthalmic solution 0.4%) in managing presbyopia by reducing pupil diameter. Dr. Florence Cabot of Bascom Palmer Eye Institute revealed that Qlosi managed to significantly reduce pupil size without inducing meaningful changes in ciliary muscle thickness or lens thickness. This contrasts sharply with the 2% concentration of pilocarpine, which showed notable effects on both ciliary muscle movement and lens thickness, particularly beneficial for near vision.

Understanding the Study's Significance

The study evaluated ten participants aged 45 to 64 years, primarily with myopia under 4 D. Patients underwent Optical Coherence Tomography (OCT) imaging before and after treatments with Qlosi, standard pilocarpine, and balanced salt solution. The data analysis revealed that while Qlosi led to a pupil diameter reduction of approximately 0.52 mm for near vision, it did not produce significant effects on the ciliary muscle response or lens thickness, which remained essentially unchanged compared to a control solution. This establishes Qlosi’s profile as pupil-selective, a crucial consideration in the treatment of presbyopia.

Implications for Patient Care in Concierge Medicine

For medical practitioners operating concierge practices, the implications of Qlosi are substantial, particularly regarding patient engagement and care strategies. The study suggests that Qlosi could be an effective non-invasive option for patients seeking relief from presbyopia without the usual side effects associated with other treatments. This is crucial as concierge medicine thrives on personalized, patient-centered care. By knowing and sharing the latest advancements in treatments, such as Qlosi, practices can strengthen their position in the local healthcare landscape, enhancing patient trust and satisfaction.

Future Directions and Patient Education

As promising as Qlosi appears, Cabot indicated that further studies are warranted to understand fully its long-term efficacy and safety. For concierge practices, it represents an opportunity to educate patients on innovative treatments that may offer improved quality of life without compromising their comfort. Fostering this knowledge can deepen patient relationships, ensuring they feel up-to-date with the latest treatment options and bolstering their loyalty.

Actionable Insights for Your Practice

Staying informed about developments in treatments can significantly enhance a concierge medical practice's offerings. Encourage staff to share these findings with patients, framing Qlosi as a groundbreaking option in discussions around age-related vision changes. Consider hosting informational sessions where patients can learn more about treatments like Qlosi and ask questions, which can empower them in their healthcare journey.